Autoinflammatory diseases.
Autoinflammatory diseases represent an expanding spectrum of genetic and non-genetic inflammatory diseases characterized by recurrent episodes of fever and systemic inflammation affecting the eyes, joints, skin, and serosal surfaces. Thus, these syndromes are recognized as disorders of innate immunity. Confirming this view, most autoinflammatory diseases are uniquely responsive to IL-1β blockade. Although many autoinflammatory diseases have a genetic cause, increasing evidence indicates that the degree of cell stress concurs to the severity of the disease phenotype. In this mini-review, I will discuss the recent advances on pathogenesis, pathophysiology and therapeutic approaches in autoinflammatory syndromes.
Cell Biology Unit, IRCCS AOU San Martino IST, 16132 Genova, Italy. Electronic address: anna.rubartelli@hsanmartino.it.
Anna
A
Rubartelli
D000818:Animals; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics; D007249:Inflammation / Q000175:diagnosis / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism; D013312:Stress, Physiological
D007375:Interleukin-1
Autoimmune; Autoinflammatory; Biologics; IL-1; NOD-like receptors; Stress